Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.25
Bid: 35.00
Ask: 35.50
Change: -0.50 (-1.40%)
Spread: 0.50 (1.429%)
Open: 35.75
High: 35.75
Low: 35.25
Prev. Close: 35.75
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM & Court Meeting

7 Jun 2010 13:03

RNS Number : 1787N
China Real Estate Opportunities PLC
07 June 2010
 



 

CHINA REAL ESTATE OPPORTUNITIES PLC

Scheme of Arrangement update: results of shareholder meetings

Further to the announcement by China Real Estate Opportunities plc ("CREO" or the "Company") on 21 May 2010 regarding the posting of the circular in relation to the listing of a Singapore Business Trust, to be known as Treasury China Trust ("TCT") of which CREO would become a 100% owned subsidiary, the associated admission of TCT to the Official List of the Singapore Stock Exchange ("SGX") and cancellation of the admission of CREO ordinary shares to AIM ("Scheme Document"), the Company is pleased to announce that at the Court Meeting and Extraordinary General Meeting held earlier today to approve the Scheme and associated matters, all resolutions were passed.

As described in the announcement made by the Company on 26 April 2010, the move to Singapore and consequent cancellation of its AIM listing, to be effected by the Scheme, is intended to position the Company closer to its asset base and facilitate demand from Asian investors.

At the Court Meeting, the required majority in number of those Scheme Shareholders present and voting, either in person or by proxy, representing 100 per cent. of the voting rights of all Scheme Shares in respect of which votes were cast, voted in favour of the Scheme. The voting of those Scheme Shareholders who cast votes either in person or by proxy at the Court Meeting was as follows:

 

Total Votes

Votes for the Scheme

Votes against the Scheme

 

No. of Scheme Shareholders

No. of Scheme Shares Represented

No. of Scheme Shareholders (and %)

No. of Scheme Shares Represented (and %)

No. of Scheme Shareholders (and %)

No. of Scheme Shares Represented (and %)

Totals in person and by proxy

 

n/a

 

n/a

 

n/a

 

n/a

 

n/a

 

n/a

329

28,077,788

329(100%)

28,077,788 (100%)

0 (0%)

0 (0%)

 

At the EGM, all of the resolutions required to implement the Scheme and certain other connected matters were passed on a poll.

In order to become operative in accordance with its terms, the Royal Court of Jersey must now sanction the Scheme at the Court Hearing. This hearing is scheduled to take place on 16 June 2010. As set out in the announcement made on 21 May 2010, trading in the CREO ordinary shares on AIM will therefore be suspended at 7.00 a.m (London time) on 16 June 2010. If the Scheme is sanctioned by the Court and becomes operative in accordance with its terms, the admission of the CREO ordinary shares to trading on AIM will be cancelled. Due to the period required to process the exchange mechanics for issuing the units in TCT, the Scheme will not become operative until 21 June 2010. On the Scheme becoming operative, CREO shareholders will receive 5 units in TCT for every one CREO share held.

It is currently expected that the units in TCT will be listed and begin trading on the Main Board of the SGX on 21 June 2010. The admission of the CREO ordinary shares to trading on AIM is therefore expected to be cancelled at 7.00 a.m. (London time) on 21 June 2010. CREO shareholders will not have to pay anything for their units in TCT.

In the event that there are any changes to the timetable, CREO will give notice of such changes by issuing an announcement to the London Stock Exchange and by notice on its website.

The Court Hearing will be heard at 9.00 a.m. (London time) on 16 June 2010 at the Royal Court of Jersey, Royal Court House, Royal Court Square, St Helier, Jersey, at which all CREO shareholders are entitled to attend in person or through Jersey advocates to support or oppose the sanctioning of the Scheme. 

Terms defined in the Scheme Document shall have the same meaning(s) when used in this announcement.

Enquiries to:

 

CREO

Ray Horney, Chairman Tel: + 44 (0) 1273 775 225

 

Sarah Moriarty, Investor Relations Tel: + 353 1 618 9455

 

 

Matrix Corporate Capital LLP Tel: + 44 (0) 20 3206 7000

Paul Fincham, Rob Naylor

 

 

Davy

Des Carville Tel: + 353 1 679 6363

 

 

Citigate Dewe Rodgerson Limited Tel: + 44 (0) 20 7638 9571

Tom Baldock

 

 

Murray Consultants

Ed Micheau Tel: + 353 1 498 0300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGGMGGVZNZGGZM
Date   Source Headline
25th Apr 20247:00 amRNSNotice of Results
24th Apr 20247:00 amRNSNHS Speedboat data demonstrates savings
20th Mar 20244:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSWelsh Labour Leader visits Creo’s facilities
13th Mar 20243:05 pmRNSHolding(s) in Company
11th Mar 20242:00 pmRNSLTIP Awards
6th Mar 20244:35 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSMicrowave Lung Ablation Update
7th Feb 20249:12 amRNSTrading Update - Replacement
7th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSStrategic Collaboration with Khalifa University
31st Jan 20247:00 amRNSSpeedboat® UltraSlim roll-out reaches Asia Pacific
22nd Jan 20247:00 amRNSAward of Shares under Share Incentive Plan
10th Jan 20247:00 amRNSFirst use of Speedboat® UltraSlim in Latin America
15th Dec 20237:00 amRNSFirst use of Speedboat® UltraSlim in the USA
13th Dec 20237:00 amRNSFirst European Speedboat® UltraSlim procedure
7th Nov 20237:00 amRNSCapital Markets Day
1st Nov 20237:00 amRNSSpeedboat® UltraSlim: US FDA Clearance
25th Oct 20237:00 amRNSSB UltraSlim: EU launch accelerated by 18 months
16th Oct 202310:16 amRNSChange of Nominated Adviser and Joint Broker
12th Oct 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results
16th Aug 20237:00 amRNSRoyal Oldham SSD service update
3rd Aug 20237:00 amRNSHalf Year Trading Update
28th Jul 20237:00 amRNSTotal Voting Rights
24th Jul 202310:40 amRNSAward of Shares under Share Incentive Plan
6th Jul 202311:33 amRNSIssue of Equity and TVR
27th Jun 20231:15 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement & Directorate Succession Planning
26th Jun 20237:00 amRNSFirst upper GI Speedboat procedure in Europe
22nd Jun 20237:00 amRNSAppointment of Marco Scarci
19th Jun 20237:00 amRNSSpeedboat Inject upper GI clearance in Europe
1st Jun 20237:00 amRNSSpeedboat™ Inject selected by NICE for assessment
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
23rd May 20237:00 amRNSFirst in-human milestone for MicroBlate™ Flex
17th May 20237:00 amRNSRoyal Oldham Hospital Agreement
15th May 20237:00 amRNSAttendance at Digestive Disease Week
26th Apr 20237:00 amRNSFinal Results
14th Apr 20237:00 amRNSAlbyn Medical earn out update
31st Mar 202310:45 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSMicroBlate™ Flex clinical study
13th Mar 20236:13 pmRNSDirector/PDMR and PCA Share Dealings
13th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 202310:25 amRNSResult of GM
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
21st Feb 202310:29 amRNSHolding(s) in Company
17th Feb 20232:05 pmRNSSecond Price Monitoring Extn
17th Feb 20232:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.